Patients have been excluded from both group when they had an additional <a href="">pdk1 inhibitors selleck</a> cancer diagnosis within five many years of diag-nosed lung cancer; if they had been inside a clinical trial for any drug besides erlotinib or pemetrexed; or if they obtained erlotinib as f